ES2082317T3 - Analogos ciclicos de vip. - Google Patents

Analogos ciclicos de vip.

Info

Publication number
ES2082317T3
ES2082317T3 ES92117185T ES92117185T ES2082317T3 ES 2082317 T3 ES2082317 T3 ES 2082317T3 ES 92117185 T ES92117185 T ES 92117185T ES 92117185 T ES92117185 T ES 92117185T ES 2082317 T3 ES2082317 T3 ES 2082317T3
Authority
ES
Spain
Prior art keywords
amino acid
vasoactive
vip
chain
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117185T
Other languages
English (en)
Spanish (es)
Inventor
David Robert Bolin
Margaret O'donnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2082317T3 publication Critical patent/ES2082317T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES92117185T 1991-10-11 1992-10-08 Analogos ciclicos de vip. Expired - Lifetime ES2082317T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77374791A 1991-10-11 1991-10-11

Publications (1)

Publication Number Publication Date
ES2082317T3 true ES2082317T3 (es) 1996-03-16

Family

ID=25099195

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117185T Expired - Lifetime ES2082317T3 (es) 1991-10-11 1992-10-08 Analogos ciclicos de vip.

Country Status (26)

Country Link
US (1) US5677419A (enExample)
EP (1) EP0536741B1 (enExample)
JP (1) JP2515473B2 (enExample)
KR (1) KR970001580B1 (enExample)
CN (3) CN1034943C (enExample)
AT (1) ATE132165T1 (enExample)
AU (1) AU656230B2 (enExample)
BG (1) BG61125B2 (enExample)
BR (1) BR9203959A (enExample)
CA (1) CA2080272C (enExample)
CZ (1) CZ281818B6 (enExample)
DE (1) DE69207138T2 (enExample)
DK (1) DK0536741T3 (enExample)
ES (1) ES2082317T3 (enExample)
FI (2) FI111646B (enExample)
GR (1) GR3019326T3 (enExample)
HU (2) HUT62606A (enExample)
IL (3) IL117252A (enExample)
MX (1) MX9205822A (enExample)
NO (3) NO304523B1 (enExample)
NZ (1) NZ244644A (enExample)
RU (1) RU2095368C1 (enExample)
SK (1) SK279399B6 (enExample)
TW (1) TW305846B (enExample)
UY (2) UY23488A1 (enExample)
ZA (1) ZA927724B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
CN1186355C (zh) * 1996-02-09 2005-01-26 霍夫曼-拉罗奇有限公司 血管活性肠肽类似物的合成
EP0975374B1 (en) 1996-07-12 2007-12-05 Immunomedics, Inc. Radiometal-binding peptide analogues
WO1998002453A2 (en) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
AU7726600A (en) * 1999-09-28 2001-04-30 Bayer Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
WO2001060862A1 (en) * 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
ATE355304T1 (de) 2000-02-18 2006-03-15 Dabur Res Foundation Radiomarkierte vip-analoge zur diagnose und therapie
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
US7507714B2 (en) * 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
AU2002220720B2 (en) 2000-11-28 2006-09-14 Mondobiotech Ag Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
CA2488358A1 (en) 2002-06-10 2003-12-18 Mondobiotech Laboratories Anstalt Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
AU2005208911A1 (en) * 2004-01-27 2005-08-11 Bayer Healthcare Llc Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
EP1781695A1 (en) * 2004-08-18 2007-05-09 Eli Lilly And Company Selective vpac2 receptor peptide agonists
RU2304146C2 (ru) * 2005-10-17 2007-08-10 Закрытое акционерное общество "Эпитек" Способ стабилизации петлеобразной структуры синтетических пептидов с помощью n- и c-концевых модификаций
CN101389647A (zh) * 2006-02-28 2009-03-18 伊莱利利公司 选择性vpac2受体肽激动剂
KR20090027239A (ko) * 2006-07-06 2009-03-16 에프. 호프만-라 로슈 아게 혈관작용성 장 펩티드의 유사체
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
JP5801807B2 (ja) 2009-08-14 2015-10-28 フェーズバイオ ファーマシューティカルズ，インコーポレイテッド 修飾された血管作動性腸管ペプチド
US9782454B2 (en) * 2010-04-22 2017-10-10 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
ES2669190T3 (es) 2011-06-06 2018-05-24 Phasebio Pharmaceuticals, Inc. Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
GB201421647D0 (en) 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
WO2016130518A2 (en) 2015-02-09 2016-08-18 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating muscle disease and disorders
CN109790202B (zh) 2016-09-30 2022-09-13 富士胶片株式会社 环肽、亲和层析载体、标记抗体、抗体药物复合体及药物制剂
WO2021167107A1 (ja) * 2020-02-22 2021-08-26 Ｊｃｒファーマ株式会社 ヒトトランスフェリンレセプター結合ペプチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
FI924580A0 (fi) 1992-10-09
JPH05213996A (ja) 1993-08-24
BG61125B2 (bg) 1996-11-29
IL103396A0 (en) 1993-03-15
NO923929D0 (no) 1992-10-09
NZ244644A (en) 1995-04-27
NO980377L (no) 1993-04-13
DE69207138D1 (de) 1996-02-08
RU2095368C1 (ru) 1997-11-10
NO980377D0 (no) 1998-01-28
IL103396A (en) 1997-11-20
CA2080272A1 (en) 1993-04-12
CN1225473C (zh) 2005-11-02
KR930007972A (ko) 1993-05-20
EP0536741B1 (en) 1995-12-27
FI924580L (fi) 1993-04-12
EP0536741A2 (en) 1993-04-14
SK279399B6 (sk) 1998-11-04
AU656230B2 (en) 1995-01-27
BR9203959A (pt) 1993-04-27
MX9205822A (es) 1993-06-01
CN1152579A (zh) 1997-06-25
FI20002041L (fi) 2000-09-15
CN1034943C (zh) 1997-05-21
EP0536741A3 (enExample) 1994-04-06
HU211534A9 (en) 1995-12-28
NO975023L (no) 1993-04-13
NO975023D0 (no) 1997-10-31
HUT62606A (en) 1993-05-28
FI20002041A7 (fi) 2000-09-15
HU9203194D0 (en) 1992-12-28
NO923929L (no) 1993-04-13
CZ281818B6 (cs) 1997-02-12
CN1153785A (zh) 1997-07-09
AU2622892A (en) 1993-04-22
CN1072415A (zh) 1993-05-26
CA2080272C (en) 2002-09-17
KR970001580B1 (ko) 1997-02-11
GR3019326T3 (en) 1996-06-30
ATE132165T1 (de) 1996-01-15
IL117252A (en) 1999-11-30
CZ308692A3 (en) 1993-08-11
IL117252A0 (en) 1996-06-18
CN1198841C (zh) 2005-04-27
JP2515473B2 (ja) 1996-07-10
DE69207138T2 (de) 1996-06-13
SK308692A3 (en) 1995-03-08
UY23488A1 (es) 1993-04-20
NO304523B1 (no) 1999-01-04
UY25084A1 (es) 1998-12-21
ZA927724B (en) 1994-04-07
DK0536741T3 (da) 1996-04-22
TW305846B (enExample) 1997-05-21
US5677419A (en) 1997-10-14
FI111646B (fi) 2003-08-29

Similar Documents

Publication Publication Date Title
UY23488A1 (es) Procedimiento para la preparacion de peptidos ciclicos vasoactivos
ES2190653T3 (es) Productos de reaccion del acido hialuronico y de aminoacidos naturales y su utilizacion en composiciones cosmeticas y farmaceuticas.
ES2153367T3 (es) Derivados de clorofila y de bacterioclorofila, su preparacion y composiciones farmaceuticas que los contienen.
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
ES2054638T3 (es) Gen codificante de los factores humanos de estimulacion colonial.
CY1121113T1 (el) Θεραπεια της νοσου ρομρε
DK0822847T3 (da) Sammensætning der fremmer indgivelse af et middel ved elektrontransport
EA200300289A1 (ru) Пептид, композиция для перорального введения, набор (варианты), способ уменьшения интенсивности симптома атеросклероза (варианты) и способ облегчения или предупреждения коронарного осложнения у млекопитающего (варианты)
ES2054878T3 (es) Expresion de la proapolipoproteina a-i humana.
ES2063011T3 (es) Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente.
BR0010700A (pt) Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata
AR029825A1 (es) Una composicion farmaceuticamente aceptable que comprende carvedilol o una sal del mismo farmaceuticamente aceptable, un procedimiento para la produccion de dicha composicion y utilizacion de la misma
HRP20020787B1 (hr) Postupak liječenja upotrebom kompleksa ligand-imunogen
CO4890856A1 (es) CICATRIZACION DE FRACTURAS USANDO ANALOGOS DE PTHrP
ES2167717T3 (es) Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
ES8608043A1 (es) Un metodo para evitar la formacion de un enlace de disulfuro en una proteina.
ES2153362T3 (es) Composiciones y procedimientos de administracion sublingual o bucal de agentes terapeuticos.
DE69939036D1 (de) PEG Konjugate von LHRH Analogen
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
ES2072875T3 (es) Conjugados de vip y de sus fragmentos activos con porciones hidrofobicas y preparacion para la utilizacion en el tratamiento de la impotencia masculina.
AR031520A1 (es) Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
ES2188604T3 (es) Inhibidores de proteasa del vih en combinaciones farmaceuticas para eltratamiento del sida.
ES2114073T3 (es) Regeneracion del higado inducida por morfogenes.
MX9302475A (es) Polipeptido de origen no natural que tiene la actividad del factor recombinante de estimulacion del receptor neu y proceso para la produccion del mis mo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536741

Country of ref document: ES